후코이단에 의한 인간 폐 섬유모세포의 활성 억제 효과

키워드

참고문헌 (30)

1. Neil Ahluwalia, "New Therapeutic Targets in Idiopathic Pulmonary Fibrosis. Aiming to Rein in Runaway Wound-Healing Responses", American Journal of Respiratory and Critical Care Medicine, 190(8), pp.867~878 (2014), American Thoracic Society[DOI]
2. Ahmed AB, "Pharmaceutical, cosmeceutical, and traditional applications of marine carbohydrates", Adv Food Nutr Res, 73, pp.197~222 (2014)[DOI]
3. K. M. Antoniou, "Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future", European Respiratory Review, 22(129), pp.281~291 (2013), European Respiratory Society (ERS)[DOI]
4. Franklin H. Epstein, "Role of Transforming Growth Factor β in Human Disease", New England Journal of Medicine, 342(18), pp.1350~1358 (2000), New England Journal of Medicine (NEJM[DOI]
5. Broekelmann TJ, "Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis", Proc Natl Acad Sci U S A, 88, pp.6642~6646 (1991)
6. Ana Camelo, "The epithelium in idiopathic pulmonary fibrosis: breaking the barrier", Frontiers in Pharmacology, 4, pp.173~ (2014), Frontiers Media SA[DOI]
7. Yuri Cho, "Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42", 44 MAPK-dependent NDRG-1, Acta Pharmaceutica Sinica B, pp.2015, 5(6)[DOI]
8. Coker RK, "Diverse cellular TGF-β1 and TGF-β3 gene expression in normal human and murine lung", Eur Respir, 9, pp.2501~2507 (1996)
9. Vincent Cottin, "Idiopathic interstitial pneumonias with connective tissue diseases features: A review", Respirology, 21(2), pp.245~258 (2016), Wiley-Blackwell[DOI]
10. K M Fries, "Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets.", American Journal of Respiratory Cell and Molecular Biology, 11(5), pp.552~560 (1994), American Thoracic Society[DOI]
11. Baoliang Guo, "MAPK", AP-1-dependent regulation of PAI-1 gene expression by TGF-β in rat mesangial cells, 2005, pp.68(3), 972~984[DOI]
12. Boris Hinz, "Formation and Function of the Myofibroblast during Tissue Repair", Journal of Investigative Dermatology, 127(3), pp.526~537 (2007), Elsevier BV[DOI]
13. Biao Hu, "Smad3 Mediates Transforming Growth Factor-β–Induced α-Smooth Muscle Actin Expression", American Journal of Respiratory Cell and Molecular Biology, 29(3), pp.397~404 (2003), American Thoracic Society[DOI]
14. Jun-O Jin, "Fucoidan Can Function as an Adjuvant In Vivo to Enhance Dendritic Cell Maturation and Function and Promote Antigen-Specific T Cell Immune Responses", PLoS ONE, 9(6), pp.e99396~ (2014), Public Library of Science (PLoS)[DOI]
15. Khalil N, "Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis", Am J Respir Cell Mol Biol, 5, pp.155~162 (1991)
16. undefined, "Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment", American Journal of Respiratory and Critical Care Medicine, 161(2), pp.646~664 (2000), American Thoracic Society[DOI]
17. Talmadge E King, "Idiopathic pulmonary fibrosis", The Lancet, 378(9807), pp.1949~1961 (2011), Elsevier BV[DOI]
18. Tatyana Kuznetsova, "Fucoidan Extracted from Fucus evanescens Prevents Endotoxin-Induced Damage in a Mouse Model of Endotoxemia", Marine Drugs, 12(2), pp.886~898 (2014), MDPI AG[DOI]
19. A. LEASK, "TGF-  signaling and the fibrotic response", The FASEB Journal, 18(7), pp.816~827 (2004), FASEB[DOI]
20. Fayong Luo, "Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo", Respiratory Research, 15(1), pp.51~ (2014), Springer Nature[DOI]
21. Meagan W. Moore, "Regulation and Relevance of Myofibroblast Responses in Idiopathic Pulmonary Fibrosis", Current Pathobiology Reports, 1(3), pp.199~208 (2013), Springer Nature[DOI]
22. O'Leary R, "Fucoidan modulates the effect of transforming growth factor(TGF)-beta1 on fibroblast proliferation and wound repopulation in in vitro models of dermal wound repair", Biol Pharm Bull, 27, pp.266~270 (2004)
23. Ruiyan Pan, "Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro", Journal of Pharmacy and Pharmacology, 68(10), pp.1320~1330 (2016), Wiley-Blackwell[DOI]
24. Park KY, "In vitro glucose and bile acid retardation effect of fucoidan from Laminaria japonica", Kor J Biotechnol Bioeng, 4, pp.265~269 (2007)
25. Mesias Pedroza, "Interleukin-6 Contributes to Inflammation and Remodeling in a Model of Adenosine Mediated Lung Injury", PLoS ONE, 6(7), pp.e22667~ (2011), Public Library of Science (PLoS)[DOI]
26. Ganesh Raghu, "Incidence and Prevalence of Idiopathic Pulmonary Fibrosis", American Journal of Respiratory and Critical Care Medicine, 174(7), pp.810~816 (2006), American Thoracic Society[DOI]
27. K.-I. Tanaka, "Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis", AJP: Lung Cellular and Molecular Physiology, 298(3), pp.L348~L360 (2010), American Physiological Society[DOI]
28. James J. Tomasek, "Myofibroblasts and mechano-regulation of connective tissue remodelling", Nature Reviews Molecular Cell Biology, 3(5), pp.349~363 (2002), Springer Nature[DOI]
29. Wang Q, "Reduction of bleomycin induced lung fibrosis by transforming growth factor beta solublereceptor in hamsters", Thorax, 54, pp.805~812 (1999)
30. 박근형, "해조류를 이용한 후코이단의 생산", KSBB Journal, 25(3), pp.223~229 (2010), 한국생물공학회

관련 논문AI추천